Cargando…

Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis

Successful therapy with anti-CD20 monoclonal antibodies (mAbs) has reinforced the key role of B cells in the immunopathology of multiple sclerosis (MS). This study aimed to determine the effects of a novel class of anti-CD20 mAbs on vascular and extravascular central nervous system (CNS)-infiltratin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tacke, Sabine, Chunder, Rittika, Schropp, Verena, Urich, Eduard, Kuerten, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949956/ https://www.ncbi.nlm.nih.gov/pubmed/35328594 http://dx.doi.org/10.3390/ijms23063172

Ejemplares similares

The presence of cerebellar B cell aggregates is associated with a specific chemokine profile in the cerebrospinal fluid in a mouse model of multiple sclerosis
por: Schropp, Verena, et al.
Publicado: (2023)

Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
por: Breakell, Thomas, et al.
Publicado: (2020)

B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation
por: Chunder, Rittika, et al.
Publicado: (2020)

Identification of a novel role for matrix metalloproteinase-3 in the modulation of B cell responses in multiple sclerosis
por: Chunder, Rittika, et al.
Publicado: (2022)

A Dual Role of Osteopontin in Modifying B Cell Responses
por: Chunder, Rittika, et al.
Publicado: (2023)

The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
por: Chunder, Rittika, et al.
Publicado: (2023)

Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab
por: Groß-Albenhausen, Elina, et al.
Publicado: (2023)

Contribution of LTi and T(H)17 cells to B cell aggregate formation in the central nervous system in a mouse model of multiple sclerosis
por: Schropp, Verena, et al.
Publicado: (2019)

Murine Esophagus Expresses Glial-Derived Central Nervous System Antigens
por: Kapitza, Christopher, et al.
Publicado: (2021)

Antibody cross-reactivity between casein and myelin-associated glycoprotein results in central nervous system demyelination
por: Chunder, Rittika, et al.
Publicado: (2022)

Nav1.6 promotes inflammation and neuronal degeneration in a mouse model of multiple sclerosis
por: Alrashdi, Barakat, et al.
Publicado: (2019)

Impact of the Voltage-Gated Calcium Channel Antagonist Nimodipine on the Development of Oligodendrocyte Precursor Cells
por: Enders, Michael, et al.
Publicado: (2023)

The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment
por: Hauser, Stephen L., et al.
Publicado: (2023)

Anti-CD20 Disrupts Meningeal B-Cell Aggregates in a Model of Secondary Progressive Multiple Sclerosis
por: Roodselaar, Jay, et al.
Publicado: (2021)

B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis
por: Tacke, Sabine, et al.
Publicado: (2021)

Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
por: Bail, Kathrin, et al.
Publicado: (2017)

Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
por: Tada, Minoru, et al.
Publicado: (2015)

A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
por: Zhang, Ran, et al.
Publicado: (2018)

Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research
por: Rottlaender, Andrea, et al.
Publicado: (2015)

CNS Cell Distribution and Axon Orientation Determine Local Spinal Cord Mechanical Properties
por: Koser, David E., et al.
Publicado: (2015)

Mice Heterozygous for the Sodium Channel Scn8a (Nav1.6) Have Reduced Inflammatory Responses During EAE and Following LPS Challenge
por: Alrashdi, Barakat, et al.
Publicado: (2021)

Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
por: Saidha, Shiv, et al.
Publicado: (2023)

KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis
por: Wunsch, Marie, et al.
Publicado: (2014)

Monoclonal antibodies targeting CD20
por: Chang, Chien-Hsing, et al.
Publicado: (2013)

Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium
por: Enders, Michael, et al.
Publicado: (2020)

A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
por: Frisch, Esther S., et al.
Publicado: (2021)

Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice
por: Keskin, Isil, et al.
Publicado: (2021)

Response to: Monoclonal antibodies targeting CD20
por: Klein, Christian, et al.
Publicado: (2013)

Chemokine Actions in the CNS: Insights from Transgenic Mice
por: Müller, Marcus, et al.
Publicado: (2008)

The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
por: Kinzel, Silke, et al.
Publicado: (2017)

Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis
por: Kleist, Christian, et al.
Publicado: (2016)

Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis
por: Kuerten, Stefanie, et al.
Publicado: (2018)

Novel CD20 monoclonal antibodies for lymphoma therapy
por: Cang, Shundong, et al.
Publicado: (2012)

Selection of an Efficient AAV Vector for Robust CNS Transgene Expression
por: Hanlon, Killian S., et al.
Publicado: (2019)

Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis
por: Salou, Marion, et al.
Publicado: (2015)

The comparative efficacy and safety of anti-CD20 monoclonal antibodies for relapsing-remitting multiple sclerosis: A network meta-analysis
por: Asha, Mohammad Z.I., et al.
Publicado: (2021)

Human Monoclonal Antibodies from Transgenic Mice
por: Lonberg, N.
Publicado: (2008)

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
por: Huang, Yi-Shu, et al.
Publicado: (2020)

Ofatumumab: a novel monoclonal anti-CD20 antibody
por: Lin, Thomas S
Publicado: (2010)

Anti-CD20 monoclonal antibodies: reviewing a revolution
por: Casan, J. M. L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_83dtpgusmc5or8108v1r4g8dk2